Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up.

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Forum - Sat. 21 May 08:30 - Sun. 22 May 18:00 Gene and cell therapy HFA Premium Access HEART FAILURE 2016

ESC 365 is supported by

ESC 365 is supported by